PATENT CLAIM ANALYSIS

Application Number: 15998437
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["514", "04400A"]

Abstract:
Compositions and methods for treatment of glioma are disclosed. In particular, the invention relates to methods of treating glioma by inhibiting pleiotrophin signaling to limit high-grade glioma invasion.

Claim (Index 1):
A method of treating glioma comprising administering to a subject in need thereof a therapeutically effective amount of at least one inhibitory nucleic acid that inhibits expression of one or more genes selected from the group consisting of PTN, HSP90B, SPARC, SPARCL1, and PTPRZ.

Metadata:
- Claim Count in Document: 4.0
- Percentile: 96.0
- Lexical Diversity: 1.24
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14386319', '15527982', '13698429', '11436244', '14200840']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7412736243395359
- 35 USC 102 Novelty (BERT): 0.4993029620061787
- Combined Prediction Score: 0.7170765581062002
- Mean Citation Score: 212.271614
- Max Citation Score: 230.1344
- Similarity Product: 156.3416168586731

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test